Healthcare -
Biotechnology - NASDAQ - US
$ 70.86
-3.59 %
$ 13.7 B
Market Cap
472.4
P/E
INCY - COST OF REVENUE
Cost of Revenue INCY - Incyte Corporation
312 M
LAST VALUE
22.78%
2 YEAR CAGR
22.26%
5 YEAR CAGR
59.09%
10 YEAR CAGR